z-logo
open-access-imgOpen Access
Ebola Hemorrhagic Fever and Septic Shock
Author(s) -
Mike Bray,
Siddhartha Mahanty
Publication year - 2003
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1086/379727
Subject(s) - septic shock , medicine , hemorrhagic shock , ebola hemorrhagic fever , intensive care medicine , viral hemorrhagic fever , ebolavirus , virology , immunology , sepsis , shock (circulatory) , ebola virus , outbreak
Ebola virus is the cause of sporadic outbreaks of lethal Ebola hemorrhagic fever (EHF) in central Africa. Despite the difficulties of studying this virus much has been learned over the past decade about the pathogenesis of Ebola virus infection in humans and nonhuman primates. Two articles in this issue of the Journal of Infectious Diseases report further progress. The article by Bosio et al. confirms findings that the virus is able to infect dendritic cells (DCs) impairing their innate antiviral activity and limiting their ability to initiate adaptive immune responses. The article by Geisbert et al. identifies a molecular trigger for disseminated intravascular coagulation (DIC) through the expression of tissue factor (TF) on the surface of virus-infected monocytes and macrophages. Together these findings shed light on early events that both permit rapid viral dissemination and cause some of the major features of EHF. (excerpt)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom